A survival analysis of 120 CRC patients suggested that the disease‐free survival (DFS) and OS of the higher KRT80 expression group were much poorer than those of the lower KRT80 expression group, and multivariate analysis showed that KRT80 expression was an independent poor prognostic factor for DFS and OS in CRC patients.23 This evidence concerns the gene KRT80 and colorectal carcinoma.